drugset / Trial / NCT02893423
Ropivacaine Transversus Abdominis Plane Blocks for Cesarean Section Analgesia
RandomizedParallel-groupDouble-blindTreatment
Summary
With this research the investigators hope to determine the lowest dose of ropivacaine used in transversus abdominis plane (TAP) blocks that can effectively treat pain in women after cesarean section (c-section).
Timeline
- Start
- 2013-01-01
- Primary completion
- 2016-09-30
- Completion
- 2016-09-30
Outcome
Outcome not reported
Stopped: “A better study with a better drug was started and thus this study was terminated”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Ropivacaine | Other / unclassified | 0 % | Other |
| Comparator | Ropivacaine | Other / unclassified | 0.25 % | Other |
| Comparator | Ropivacaine | Other / unclassified | 0.5 % | Other |
Indications
No indication recorded.